Cirtociclib

N/A

Report date: 2026/01/16 15:31:49

Base Information

Drug NameCirtociclib
Drug Alias NameCertociclibBLU-222BLU-17029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsEsophageal adenocarcinomaSolid tumoursEndometrial Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlueprint Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsEsophageal adenocarcinomaEndometrial NeoplasmsOvarian Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A